Eli Lilly and Co. (NYSE:LLY) stock is trading higher after the company released better-than-expected Q4 earnings and issued fiscal 2026 guidance. Earnings Overview Eli Lilly reported fourth-quarter ad[...]
Read more
Articles written by Vandana Singh
FDA Strikes Off European Biotech Pharming’s Immune Deficiency Drug for Expanded Use in Pediatric Patients
The U.S. Food and Drug Administration (FDA) on Friday issued a Complete Response Letter (CRL) to Pharming Group’s (NASDAQ:PHAR) supplemental New Drug Application (sNDA) for Joenja (leniolisib) for chi[...]
Read moreJohnson & Johnson Wins FDA Nod for First Precision Combo for Mutated Prostate Cancer
On Friday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s (NYSE:JNJ) supplemental New Drug Application (sNDA) for Akeega (niraparib and abiraterone acetate) plus pr[...]
Read more